Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Clin Hypertens (Greenwich) ; 22(4): 642-648, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32108425

RESUMO

This paper proposes a costing tool for hypertension and cardiovascular disease by adapting cost-of-illness methodologies to estimate the attributable burden of excessive salt intake on cardiovascular disease. The methodology estimates the changes in blood pressure that result from each gram change in salt intake and links diet to the direct and indirect costs of cardiovascular diseases (CVD), such as coronary heart disease, stroke, hypertensive disease, aortic aneurysm, heart failure, pulmonary embolism, and rheumatic heart, using the relative risks of disease and the prevalence of salt consumption in the population. The methodology includes (a) identifying major diseases and conditions related to excessive salt intake and relevant economic cost data available, (b) quantifying the relationship between the prevalence of excessive salt intake and the associated risk of disease morbidity and mortality using population attributable risks (PAR), (c) using PARs to estimate the share of total costs directly attributed to excessive salt intake, and (d) undertaking a sensitivity analysis of key epidemiological and economic parameters. The costing tool has estimated that, in 2013, US$ 102.0 million (95% uncertainty interval-UI: US$ 96.2-107.8 million) in public hospitalizations could be saved if the average salt intake of Brazilians were reduced to 5 g/d, corresponding to 9.4% (95% UI: 8.9%-9.9%) of the total hospital costs by CVDs. This methodology of cost of illness associated with salt consumption can be adapted to estimate the burden of other dietary risk factors and support prevention and control policies in Brazil and in other countries.


Assuntos
Doenças Cardiovasculares , Hipertensão , Brasil , Doenças Cardiovasculares/epidemiologia , Humanos , Hipertensão/epidemiologia , Sódio , Cloreto de Sódio na Dieta/efeitos adversos
2.
PLoS One ; 13(4): e0194801, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29649221

RESUMO

BACKGROUND: The comparison between long acting insulin analogues (LAIA) and human insulin (NPH) has been investigated for decades, with many randomized controlled trials (RCTs) and systematic reviews giving mixed results. This overlapping and contradictory evidence has increased uncertainty on coverage decisions at health systems level. AIM: To conduct an overview of systematic reviews and update existing reviews, preparing new meta-analysis to determine whether LAIA are effective for T1D patients compared to NPH. METHODS: We identified systematic reviews of RCTs that evaluated the efficacy of LAIA glargine or detemir, compared to NPH insulin for T1D, assessing glycated hemoglobin (A1C) and hypoglycemia. Data sources included Pubmed, Cochrane Library, EMBASE and hand-searching. The methodological quality of studies was independently assessed by two reviewers, using AMSTAR and Jadad scale. We found 11 eligible systematic reviews that contained a total of 25 relevant clinical trials. Two reviewers independently abstracted data. RESULTS: We found evidence that LAIA are efficacious compared to NPH, with estimates showing a reduction in nocturnal hypoglycemia episodes (RR 0.66; 95% CI 0.57; 0.76) and A1C (95% CI 0.23; 0.12). No significance was found related to severe hypoglycemia (RR 0.94; 95% CI 0.71; 1.24). CONCLUSION: This study design has allowed us to carry out the most comprehensive assessment of RCTs on this subject, filling a gap in diabetes research. Our paper addresses a question that is important not only for decision makers but also for clinicians.


Assuntos
Diabetes Mellitus Tipo 1/tratamento farmacológico , Insulina de Ação Prolongada/uso terapêutico , Hemoglobinas Glicadas/química , Humanos , Hipoglicemia/tratamento farmacológico , Hipoglicemiantes/uso terapêutico , Insulina Detemir/uso terapêutico , Insulina Glargina/uso terapêutico , Modelos Estatísticos , Ensaios Clínicos Controlados Aleatórios como Assunto , Análise de Regressão
3.
Arq Bras Cir Dig ; 27 Suppl 1: 39-42, 2014.
Artigo em Inglês, Português | MEDLINE | ID: mdl-25409964

RESUMO

BACKGROUND: Although Brazilian National Public Health System (BNPHS) has presented advances regarding the treatment for obesity in the last years, there is a repressed demand for bariatric surgeries in the country. Despite favorable evidences to laparoscopy, the BNPHS only performs this procedure via laparotomy. AIM: 1) Estimate whether bariatric surgeons would support the idea of incorporating laparoscopic surgery in the BNPHS; 2) If there would be an increase in the total number of surgeries performed; 3) As well as how BNPHS would redistribute both procedures. METHODS: A panel of bariatric surgeons was built. Two rounds to answer the structured Delphi questionnaire were performed. RESULTS: From the 45 bariatric surgeons recruited, 30 (66.7%) participated in the first round. For the second (the last) round, from the 30 surgeons who answered the first round, 22 (48.9%) answered the questionnaire. Considering the possibility that BNPHS incorporated laparoscopic surgery, 95% of surgeons were interested in performing it. Therefore, in case laparoscopic surgery was incorporated by the BNPHS there would be an average increase of 25% in the number of surgeries and they would be distributed as follows: 62.5% via laparoscopy and 37.5% via laparotomy. CONCLUSION: 1) There was a preference by laparoscopy; 2) would increase the number of operations compared to the current model in which only the laparotomy is available to users of the public system; and 3) the distribution in relation to the type of procedure would be 62.5% and 37.5% for laparoscopy laparotomy.


Assuntos
Atitude do Pessoal de Saúde , Cirurgia Bariátrica , Atenção à Saúde , Laparoscopia , Cirurgiões , Cirurgia Bariátrica/métodos , Brasil , Humanos , Laparotomia , Saúde Pública , Inquéritos e Questionários
4.
ABCD (São Paulo, Impr.) ; 27(supl.1): 39-42, 2014. tab
Artigo em Inglês | LILACS | ID: lil-728632

RESUMO

BACKGROUND: Although Brazilian National Public Health System (BNPHS) has presented advances regarding the treatment for obesity in the last years, there is a repressed demand for bariatric surgeries in the country. Despite favorable evidences to laparoscopy, the BNPHS only performs this procedure via laparotomy. AIM: 1) Estimate whether bariatric surgeons would support the idea of incorporating laparoscopic surgery in the BNPHS; 2) If there would be an increase in the total number of surgeries performed; 3) As well as how BNPHS would redistribute both procedures. METHODS: A panel of bariatric surgeons was built. Two rounds to answer the structured Delphi questionnaire were performed. RESULTS: From the 45 bariatric surgeons recruited, 30 (66.7%) participated in the first round. For the second (the last) round, from the 30 surgeons who answered the first round, 22 (48.9%) answered the questionnaire. Considering the possibility that BNPHS incorporated laparoscopic surgery, 95% of surgeons were interested in performing it. Therefore, in case laparoscopic surgery was incorporated by the BNPHS there would be an average increase of 25% in the number of surgeries and they would be distributed as follows: 62.5% via laparoscopy and 37.5% via laparotomy. CONCLUSION: 1) There was a preference by laparoscopy; 2) would increase the number of operations compared to the current model in which only the laparotomy is available to users of the public system; and 3) the distribution in relation to the type of procedure would be 62.5% and 37.5% for laparoscopy laparotomy. .


RACIONAL: Nos últimos anos, apesar do Sistema Único de Saúde Brasileiro - SUS - apresentar avanços relacionados à organização e ampliação das ações voltadas à prevenção e ao tratamento da obesidade, existe demanda reprimida de operações no país. Mesmo com evidências favoráveis à operação por via laparoscópica, o SUS só permite o procedimento por via laparotômica. OBJETIVOS: 1) Estimar se os cirurgiões bariátricos apoiariam eventual incorporação da operação por via laparoscópica no SUS; 2) se haveria incremento no número total de operações caso houvesse esta nova opção de via de acesso; e 3) como seria a redistribuição da oferta de operações pelas duas vias. MÉTODOS: Com o método Delphi, foi construído um painel de especialistas, em que cirurgiões bariátricos responderam um questionário estruturado previamente desenvolvido para esse fim. Foram realizadas duas rodadas, no intuito de melhor consenso. RESULTADOS: Dos 45 cirurgiões que estiveram presentes no evento nacional, 30 (66,7%) participaram do questionário Delphi, o que correspondeu à primeira rodada do estudo. Na segunda, e última rodada, dos 30 respondentes da primeira etapa, 22 (48,9%) cirurgiões responderam. Mediante a possibilidade de incorporação da via laparoscópica no SUS, aproximadamente 95% dos cirurgiões manifestaram interesse em realizá-la. Caso a operação por laparoscopia fosse incorporada no SUS, haveria incremento médio no número de operações na ordem de 25%; nesta nova configuração, a oferta de procedimentos cirúrgicos estaria distribuída da seguinte forma: 62,5% por laparoscopia e 37,5% por laparotomia. CONCLUSÃO: ...


Assuntos
Humanos , Atitude do Pessoal de Saúde , Cirurgia Bariátrica , Atenção à Saúde , Laparoscopia , Cirurgiões , Cirurgia Bariátrica/métodos , Brasil , Laparotomia , Saúde Pública , Inquéritos e Questionários
5.
Int J Technol Assess Health Care ; 28(2): 86-92, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22559750

RESUMO

OBJECTIVES: The aim of this study was to summarize and assess economic evaluations of poison centers (PCs) from the perspectives of society, the payer, and the healthcare system. METHODS: A systematic review was performed to identify complete economic evaluations regardless of the language or publication status. Two reviewers evaluated the abstracts for eligibility, extracted the data, and assessed the study quality using a standardized tool. RESULTS: In total, 422 non-duplicated studies were retrieved, but only nine met the eligibility criteria. Five of the eligible studies were published in the 1990s, and four were published in the 2000s. Six studies met at least seven of ten quality criteria. In all studies, the presence of PCs was compared with a scenario of their absence. Eight studies used cost-benefit analyses and one used a cost-effectiveness approach. The cost-benefit ratios ranged from 0.76 to 7.67, which indicates that each United States dollar (USD) spent on poison centers can save almost 8 USD on medical spending. A cost-effectiveness analysis showed that each successful outcome achieved by a PC avoids a minimum of 12,000 USD to 56,000 USD in other healthcare spending. CONCLUSIONS: The data in our review show that PCs are economically viable. PCs improve the efficiency of healthcare expenditure and contribute to the sustainability of the healthcare system. An investment in PCs is a rational public health policy approach that contrasts the current trend of reducing spending on PCs.


Assuntos
Centros de Controle de Intoxicações/economia , Intoxicação/economia , Brasil/epidemiologia , Análise Custo-Benefício , Humanos , Centros de Controle de Intoxicações/estatística & dados numéricos , Intoxicação/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA